OBJECTIVES: (1)Survey to estimate  the monthly expenditure of a Type II Diabetes patient in Mumbai . (2)To project the fact that even in absence of health insurance policies by  government for its citizens, patients receive free or cost subsidized treatment  in the government hospitals. (3)Explore government initiatives in regulating the price of the Diabetes II drugs. METHODS: Three sets of structured questionnaires were designed which captured the patient demographics,prescription trends of type II Diabetes patients in Mumbai,India.The survey through questionnaires targeted three government secondary hospitals,two government tertiary hospitals,35 General Practioners,50 Drug stores. RESULTS: (1) 46%of the patients detected with type II Diabetes lie in the age group of  50-60 years. (2)Amongst them the population of males affected is little more than females ie.51% males vs 46% females. (3)The trend of drugs as  prescribed by the General Practioners is same as that of drug prescriptions received by drug stores.The Metformin containing generic brands which fall under The Drug Price Control Order(DPCO) 2013 (cap price removed)is majorly prescribed followed by glypizides , acarbose and pioglitazone containing generic brands. CONCLUSIONS: : (1)The monthly expenditure of a Type II Diabetes patient in Mumbai is Rs.300 (USD 4.8)when the patient is treated by GP and purchases the drug from the drug stores. (2)The patients are either treated free or in subsidized rates in government hospitals.ie.in 2.4USD per month. (3)The metformin category drugs coming under DPCO 2013 are the majorly prescribed drugs.    Thus it is very easy and convenient for type II Diabetes patients in Mumbai to suffice their medical needs in the most reasonable and affordable price and also get free treatment from tertiary government hospitals.Although a federal/government health insurance policy does not exist in India the government through its subsidies or free treatments rightly makes this therapy  accessible to the common man of the city.